nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CYP2B6—Ifosfamide—testicular cancer	0.0999	0.177	CbGbCtD
Paroxetine—CYP2C8—Ifosfamide—testicular cancer	0.0757	0.134	CbGbCtD
Paroxetine—CYP2C9—Ifosfamide—testicular cancer	0.0528	0.0933	CbGbCtD
Paroxetine—CYP2B6—Cisplatin—testicular cancer	0.0486	0.0859	CbGbCtD
Paroxetine—ABCB1—Dactinomycin—testicular cancer	0.0434	0.0767	CbGbCtD
Paroxetine—CYP2C8—Etoposide—testicular cancer	0.0362	0.0639	CbGbCtD
Paroxetine—CYP2B6—Doxorubicin—testicular cancer	0.0326	0.0576	CbGbCtD
Paroxetine—ABCB1—Vinblastine—testicular cancer	0.0272	0.048	CbGbCtD
Paroxetine—CYP2C9—Cisplatin—testicular cancer	0.0257	0.0454	CbGbCtD
Paroxetine—CYP2D6—Vinblastine—testicular cancer	0.0256	0.0453	CbGbCtD
Paroxetine—ABCB1—Cisplatin—testicular cancer	0.0249	0.0441	CbGbCtD
Paroxetine—ABCB1—Etoposide—testicular cancer	0.0245	0.0433	CbGbCtD
Paroxetine—ABCB1—Doxorubicin—testicular cancer	0.0167	0.0295	CbGbCtD
Paroxetine—ABCB1—Methotrexate—testicular cancer	0.0162	0.0286	CbGbCtD
Paroxetine—CYP2D6—Doxorubicin—testicular cancer	0.0157	0.0278	CbGbCtD
Paroxetine—Tinnitus—Methotrexate—testicular cancer	0.000135	0.00031	CcSEcCtD
Paroxetine—Hypoaesthesia—Epirubicin—testicular cancer	0.000135	0.00031	CcSEcCtD
Paroxetine—Asthenia—Cisplatin—testicular cancer	0.000134	0.000309	CcSEcCtD
Paroxetine—Pharyngitis—Epirubicin—testicular cancer	0.000134	0.000309	CcSEcCtD
Paroxetine—Cardiac disorder—Methotrexate—testicular cancer	0.000134	0.000309	CcSEcCtD
Paroxetine—Sweating—Doxorubicin—testicular cancer	0.000134	0.000308	CcSEcCtD
Paroxetine—Oedema peripheral—Epirubicin—testicular cancer	0.000133	0.000307	CcSEcCtD
Paroxetine—Haematuria—Doxorubicin—testicular cancer	0.000133	0.000306	CcSEcCtD
Paroxetine—Connective tissue disorder—Epirubicin—testicular cancer	0.000133	0.000306	CcSEcCtD
Paroxetine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000132	0.000304	CcSEcCtD
Paroxetine—Epistaxis—Doxorubicin—testicular cancer	0.000132	0.000303	CcSEcCtD
Paroxetine—Angiopathy—Methotrexate—testicular cancer	0.000131	0.000302	CcSEcCtD
Paroxetine—Sinusitis—Doxorubicin—testicular cancer	0.000131	0.000301	CcSEcCtD
Paroxetine—Immune system disorder—Methotrexate—testicular cancer	0.000131	0.000301	CcSEcCtD
Paroxetine—Visual impairment—Epirubicin—testicular cancer	0.00013	0.0003	CcSEcCtD
Paroxetine—Mediastinal disorder—Methotrexate—testicular cancer	0.00013	0.0003	CcSEcCtD
Paroxetine—Agranulocytosis—Doxorubicin—testicular cancer	0.00013	0.0003	CcSEcCtD
Paroxetine—Chills—Methotrexate—testicular cancer	0.00013	0.000299	CcSEcCtD
Paroxetine—Nausea—Ifosfamide—testicular cancer	0.000129	0.000297	CcSEcCtD
Paroxetine—Diarrhoea—Cisplatin—testicular cancer	0.000128	0.000295	CcSEcCtD
Paroxetine—Erythema multiforme—Epirubicin—testicular cancer	0.000128	0.000295	CcSEcCtD
Paroxetine—Alopecia—Methotrexate—testicular cancer	0.000128	0.000294	CcSEcCtD
Paroxetine—Bradycardia—Doxorubicin—testicular cancer	0.000127	0.000293	CcSEcCtD
Paroxetine—Mental disorder—Methotrexate—testicular cancer	0.000127	0.000292	CcSEcCtD
Paroxetine—Eye disorder—Epirubicin—testicular cancer	0.000126	0.000291	CcSEcCtD
Paroxetine—Hypersensitivity—Etoposide—testicular cancer	0.000126	0.000291	CcSEcCtD
Paroxetine—Tinnitus—Epirubicin—testicular cancer	0.000126	0.00029	CcSEcCtD
Paroxetine—Erythema—Methotrexate—testicular cancer	0.000126	0.00029	CcSEcCtD
Paroxetine—Malnutrition—Methotrexate—testicular cancer	0.000126	0.00029	CcSEcCtD
Paroxetine—Haemoglobin—Doxorubicin—testicular cancer	0.000126	0.00029	CcSEcCtD
Paroxetine—Cardiac disorder—Epirubicin—testicular cancer	0.000126	0.000289	CcSEcCtD
Paroxetine—Flushing—Epirubicin—testicular cancer	0.000126	0.000289	CcSEcCtD
Paroxetine—Rhinitis—Doxorubicin—testicular cancer	0.000125	0.000289	CcSEcCtD
Paroxetine—Haemorrhage—Doxorubicin—testicular cancer	0.000125	0.000288	CcSEcCtD
Paroxetine—Hepatitis—Doxorubicin—testicular cancer	0.000125	0.000288	CcSEcCtD
Paroxetine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000125	0.000287	CcSEcCtD
Paroxetine—Pharyngitis—Doxorubicin—testicular cancer	0.000124	0.000286	CcSEcCtD
Paroxetine—Oedema peripheral—Doxorubicin—testicular cancer	0.000123	0.000284	CcSEcCtD
Paroxetine—Dysgeusia—Methotrexate—testicular cancer	0.000123	0.000284	CcSEcCtD
Paroxetine—Asthenia—Etoposide—testicular cancer	0.000123	0.000283	CcSEcCtD
Paroxetine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000123	0.000283	CcSEcCtD
Paroxetine—Angiopathy—Epirubicin—testicular cancer	0.000123	0.000283	CcSEcCtD
Paroxetine—Immune system disorder—Epirubicin—testicular cancer	0.000122	0.000281	CcSEcCtD
Paroxetine—Mediastinal disorder—Epirubicin—testicular cancer	0.000122	0.000281	CcSEcCtD
Paroxetine—Back pain—Methotrexate—testicular cancer	0.000122	0.00028	CcSEcCtD
Paroxetine—Chills—Epirubicin—testicular cancer	0.000121	0.000279	CcSEcCtD
Paroxetine—Pruritus—Etoposide—testicular cancer	0.000121	0.000279	CcSEcCtD
Paroxetine—Arrhythmia—Epirubicin—testicular cancer	0.000121	0.000278	CcSEcCtD
Paroxetine—Visual impairment—Doxorubicin—testicular cancer	0.000121	0.000278	CcSEcCtD
Paroxetine—Alopecia—Epirubicin—testicular cancer	0.00012	0.000275	CcSEcCtD
Paroxetine—Vomiting—Cisplatin—testicular cancer	0.000119	0.000274	CcSEcCtD
Paroxetine—Vision blurred—Methotrexate—testicular cancer	0.000119	0.000273	CcSEcCtD
Paroxetine—Mental disorder—Epirubicin—testicular cancer	0.000119	0.000273	CcSEcCtD
Paroxetine—Erythema multiforme—Doxorubicin—testicular cancer	0.000118	0.000273	CcSEcCtD
Paroxetine—Rash—Cisplatin—testicular cancer	0.000118	0.000272	CcSEcCtD
Paroxetine—Dermatitis—Cisplatin—testicular cancer	0.000118	0.000271	CcSEcCtD
Paroxetine—Erythema—Epirubicin—testicular cancer	0.000118	0.000271	CcSEcCtD
Paroxetine—Malnutrition—Epirubicin—testicular cancer	0.000118	0.000271	CcSEcCtD
Paroxetine—Diarrhoea—Etoposide—testicular cancer	0.000117	0.00027	CcSEcCtD
Paroxetine—Eye disorder—Doxorubicin—testicular cancer	0.000117	0.000269	CcSEcCtD
Paroxetine—Ill-defined disorder—Methotrexate—testicular cancer	0.000117	0.000269	CcSEcCtD
Paroxetine—Tinnitus—Doxorubicin—testicular cancer	0.000117	0.000269	CcSEcCtD
Paroxetine—Anaemia—Methotrexate—testicular cancer	0.000116	0.000268	CcSEcCtD
Paroxetine—Flushing—Doxorubicin—testicular cancer	0.000116	0.000267	CcSEcCtD
Paroxetine—Cardiac disorder—Doxorubicin—testicular cancer	0.000116	0.000267	CcSEcCtD
Paroxetine—Flatulence—Epirubicin—testicular cancer	0.000116	0.000267	CcSEcCtD
Paroxetine—Tension—Epirubicin—testicular cancer	0.000116	0.000266	CcSEcCtD
Paroxetine—Dysgeusia—Epirubicin—testicular cancer	0.000115	0.000266	CcSEcCtD
Paroxetine—Nervousness—Epirubicin—testicular cancer	0.000114	0.000263	CcSEcCtD
Paroxetine—Back pain—Epirubicin—testicular cancer	0.000114	0.000262	CcSEcCtD
Paroxetine—Angiopathy—Doxorubicin—testicular cancer	0.000114	0.000261	CcSEcCtD
Paroxetine—Malaise—Methotrexate—testicular cancer	0.000113	0.000261	CcSEcCtD
Paroxetine—Dizziness—Etoposide—testicular cancer	0.000113	0.000261	CcSEcCtD
Paroxetine—Muscle spasms—Epirubicin—testicular cancer	0.000113	0.000261	CcSEcCtD
Paroxetine—Immune system disorder—Doxorubicin—testicular cancer	0.000113	0.00026	CcSEcCtD
Paroxetine—Vertigo—Methotrexate—testicular cancer	0.000113	0.00026	CcSEcCtD
Paroxetine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000113	0.00026	CcSEcCtD
Paroxetine—Leukopenia—Methotrexate—testicular cancer	0.000113	0.000259	CcSEcCtD
Paroxetine—Chills—Doxorubicin—testicular cancer	0.000112	0.000259	CcSEcCtD
Paroxetine—Arrhythmia—Doxorubicin—testicular cancer	0.000112	0.000257	CcSEcCtD
Paroxetine—Nausea—Cisplatin—testicular cancer	0.000111	0.000256	CcSEcCtD
Paroxetine—Vision blurred—Epirubicin—testicular cancer	0.000111	0.000256	CcSEcCtD
Paroxetine—Alopecia—Doxorubicin—testicular cancer	0.000111	0.000255	CcSEcCtD
Paroxetine—Cough—Methotrexate—testicular cancer	0.00011	0.000253	CcSEcCtD
Paroxetine—Mental disorder—Doxorubicin—testicular cancer	0.00011	0.000252	CcSEcCtD
Paroxetine—Ill-defined disorder—Epirubicin—testicular cancer	0.000109	0.000252	CcSEcCtD
Paroxetine—Convulsion—Methotrexate—testicular cancer	0.000109	0.000251	CcSEcCtD
Paroxetine—Vomiting—Etoposide—testicular cancer	0.000109	0.000251	CcSEcCtD
Paroxetine—Erythema—Doxorubicin—testicular cancer	0.000109	0.000251	CcSEcCtD
Paroxetine—Malnutrition—Doxorubicin—testicular cancer	0.000109	0.000251	CcSEcCtD
Paroxetine—Anaemia—Epirubicin—testicular cancer	0.000109	0.000251	CcSEcCtD
Paroxetine—Agitation—Epirubicin—testicular cancer	0.000108	0.000249	CcSEcCtD
Paroxetine—Rash—Etoposide—testicular cancer	0.000108	0.000249	CcSEcCtD
Paroxetine—Dermatitis—Etoposide—testicular cancer	0.000108	0.000249	CcSEcCtD
Paroxetine—Headache—Etoposide—testicular cancer	0.000107	0.000247	CcSEcCtD
Paroxetine—Flatulence—Doxorubicin—testicular cancer	0.000107	0.000247	CcSEcCtD
Paroxetine—Arthralgia—Methotrexate—testicular cancer	0.000107	0.000247	CcSEcCtD
Paroxetine—Myalgia—Methotrexate—testicular cancer	0.000107	0.000247	CcSEcCtD
Paroxetine—Chest pain—Methotrexate—testicular cancer	0.000107	0.000247	CcSEcCtD
Paroxetine—Tension—Doxorubicin—testicular cancer	0.000107	0.000246	CcSEcCtD
Paroxetine—Dysgeusia—Doxorubicin—testicular cancer	0.000107	0.000246	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000106	0.000245	CcSEcCtD
Paroxetine—Malaise—Epirubicin—testicular cancer	0.000106	0.000245	CcSEcCtD
Paroxetine—Discomfort—Methotrexate—testicular cancer	0.000106	0.000244	CcSEcCtD
Paroxetine—Nervousness—Doxorubicin—testicular cancer	0.000106	0.000244	CcSEcCtD
Paroxetine—Vertigo—Epirubicin—testicular cancer	0.000106	0.000244	CcSEcCtD
Paroxetine—Syncope—Epirubicin—testicular cancer	0.000106	0.000243	CcSEcCtD
Paroxetine—Leukopenia—Epirubicin—testicular cancer	0.000105	0.000243	CcSEcCtD
Paroxetine—Back pain—Doxorubicin—testicular cancer	0.000105	0.000243	CcSEcCtD
Paroxetine—Muscle spasms—Doxorubicin—testicular cancer	0.000105	0.000241	CcSEcCtD
Paroxetine—Palpitations—Epirubicin—testicular cancer	0.000104	0.00024	CcSEcCtD
Paroxetine—Confusional state—Methotrexate—testicular cancer	0.000104	0.000238	CcSEcCtD
Paroxetine—Loss of consciousness—Epirubicin—testicular cancer	0.000103	0.000238	CcSEcCtD
Paroxetine—Cough—Epirubicin—testicular cancer	0.000103	0.000237	CcSEcCtD
Paroxetine—Anaphylactic shock—Methotrexate—testicular cancer	0.000103	0.000236	CcSEcCtD
Paroxetine—Vision blurred—Doxorubicin—testicular cancer	0.000103	0.000236	CcSEcCtD
Paroxetine—Convulsion—Epirubicin—testicular cancer	0.000102	0.000235	CcSEcCtD
Paroxetine—Infection—Methotrexate—testicular cancer	0.000102	0.000235	CcSEcCtD
Paroxetine—Nausea—Etoposide—testicular cancer	0.000102	0.000234	CcSEcCtD
Paroxetine—Hypertension—Epirubicin—testicular cancer	0.000102	0.000234	CcSEcCtD
Paroxetine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000101	0.000233	CcSEcCtD
Paroxetine—Nervous system disorder—Methotrexate—testicular cancer	0.000101	0.000232	CcSEcCtD
Paroxetine—Anaemia—Doxorubicin—testicular cancer	0.000101	0.000232	CcSEcCtD
Paroxetine—Thrombocytopenia—Methotrexate—testicular cancer	0.000101	0.000232	CcSEcCtD
Paroxetine—Myalgia—Epirubicin—testicular cancer	0.0001	0.000231	CcSEcCtD
Paroxetine—Chest pain—Epirubicin—testicular cancer	0.0001	0.000231	CcSEcCtD
Paroxetine—Arthralgia—Epirubicin—testicular cancer	0.0001	0.000231	CcSEcCtD
Paroxetine—Agitation—Doxorubicin—testicular cancer	0.0001	0.000231	CcSEcCtD
Paroxetine—Anxiety—Epirubicin—testicular cancer	9.99e-05	0.00023	CcSEcCtD
Paroxetine—Skin disorder—Methotrexate—testicular cancer	9.97e-05	0.00023	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	9.96e-05	0.000229	CcSEcCtD
Paroxetine—Hyperhidrosis—Methotrexate—testicular cancer	9.93e-05	0.000229	CcSEcCtD
Paroxetine—Discomfort—Epirubicin—testicular cancer	9.9e-05	0.000228	CcSEcCtD
Paroxetine—Malaise—Doxorubicin—testicular cancer	9.83e-05	0.000226	CcSEcCtD
Paroxetine—Dry mouth—Epirubicin—testicular cancer	9.8e-05	0.000226	CcSEcCtD
Paroxetine—Vertigo—Doxorubicin—testicular cancer	9.79e-05	0.000225	CcSEcCtD
Paroxetine—Syncope—Doxorubicin—testicular cancer	9.77e-05	0.000225	CcSEcCtD
Paroxetine—Leukopenia—Doxorubicin—testicular cancer	9.75e-05	0.000225	CcSEcCtD
Paroxetine—Confusional state—Epirubicin—testicular cancer	9.69e-05	0.000223	CcSEcCtD
Paroxetine—Palpitations—Doxorubicin—testicular cancer	9.63e-05	0.000222	CcSEcCtD
Paroxetine—Oedema—Epirubicin—testicular cancer	9.61e-05	0.000221	CcSEcCtD
Paroxetine—Anaphylactic shock—Epirubicin—testicular cancer	9.61e-05	0.000221	CcSEcCtD
Paroxetine—Hypotension—Methotrexate—testicular cancer	9.6e-05	0.000221	CcSEcCtD
Paroxetine—Loss of consciousness—Doxorubicin—testicular cancer	9.58e-05	0.000221	CcSEcCtD
Paroxetine—Infection—Epirubicin—testicular cancer	9.55e-05	0.00022	CcSEcCtD
Paroxetine—Cough—Doxorubicin—testicular cancer	9.51e-05	0.000219	CcSEcCtD
Paroxetine—Shock—Epirubicin—testicular cancer	9.45e-05	0.000218	CcSEcCtD
Paroxetine—Convulsion—Doxorubicin—testicular cancer	9.44e-05	0.000217	CcSEcCtD
Paroxetine—Nervous system disorder—Epirubicin—testicular cancer	9.42e-05	0.000217	CcSEcCtD
Paroxetine—Thrombocytopenia—Epirubicin—testicular cancer	9.41e-05	0.000217	CcSEcCtD
Paroxetine—Hypertension—Doxorubicin—testicular cancer	9.41e-05	0.000217	CcSEcCtD
Paroxetine—Tachycardia—Epirubicin—testicular cancer	9.38e-05	0.000216	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methotrexate—testicular cancer	9.36e-05	0.000215	CcSEcCtD
Paroxetine—Skin disorder—Epirubicin—testicular cancer	9.33e-05	0.000215	CcSEcCtD
Paroxetine—Hyperhidrosis—Epirubicin—testicular cancer	9.29e-05	0.000214	CcSEcCtD
Paroxetine—Insomnia—Methotrexate—testicular cancer	9.29e-05	0.000214	CcSEcCtD
Paroxetine—Myalgia—Doxorubicin—testicular cancer	9.28e-05	0.000214	CcSEcCtD
Paroxetine—Chest pain—Doxorubicin—testicular cancer	9.28e-05	0.000214	CcSEcCtD
Paroxetine—Arthralgia—Doxorubicin—testicular cancer	9.28e-05	0.000214	CcSEcCtD
Paroxetine—Anxiety—Doxorubicin—testicular cancer	9.24e-05	0.000213	CcSEcCtD
Paroxetine—Paraesthesia—Methotrexate—testicular cancer	9.22e-05	0.000212	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	9.21e-05	0.000212	CcSEcCtD
Paroxetine—Discomfort—Doxorubicin—testicular cancer	9.16e-05	0.000211	CcSEcCtD
Paroxetine—Dyspnoea—Methotrexate—testicular cancer	9.16e-05	0.000211	CcSEcCtD
Paroxetine—Somnolence—Methotrexate—testicular cancer	9.13e-05	0.00021	CcSEcCtD
Paroxetine—Dry mouth—Doxorubicin—testicular cancer	9.07e-05	0.000209	CcSEcCtD
Paroxetine—Dyspepsia—Methotrexate—testicular cancer	9.04e-05	0.000208	CcSEcCtD
Paroxetine—Hypotension—Epirubicin—testicular cancer	8.98e-05	0.000207	CcSEcCtD
Paroxetine—Confusional state—Doxorubicin—testicular cancer	8.97e-05	0.000206	CcSEcCtD
Paroxetine—Decreased appetite—Methotrexate—testicular cancer	8.93e-05	0.000206	CcSEcCtD
Paroxetine—Oedema—Doxorubicin—testicular cancer	8.89e-05	0.000205	CcSEcCtD
Paroxetine—Anaphylactic shock—Doxorubicin—testicular cancer	8.89e-05	0.000205	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Methotrexate—testicular cancer	8.87e-05	0.000204	CcSEcCtD
Paroxetine—Fatigue—Methotrexate—testicular cancer	8.85e-05	0.000204	CcSEcCtD
Paroxetine—Infection—Doxorubicin—testicular cancer	8.83e-05	0.000203	CcSEcCtD
Paroxetine—Pain—Methotrexate—testicular cancer	8.78e-05	0.000202	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Epirubicin—testicular cancer	8.76e-05	0.000202	CcSEcCtD
Paroxetine—Shock—Doxorubicin—testicular cancer	8.75e-05	0.000201	CcSEcCtD
Paroxetine—Nervous system disorder—Doxorubicin—testicular cancer	8.72e-05	0.000201	CcSEcCtD
Paroxetine—Thrombocytopenia—Doxorubicin—testicular cancer	8.71e-05	0.0002	CcSEcCtD
Paroxetine—Insomnia—Epirubicin—testicular cancer	8.69e-05	0.0002	CcSEcCtD
Paroxetine—Tachycardia—Doxorubicin—testicular cancer	8.68e-05	0.0002	CcSEcCtD
Paroxetine—Skin disorder—Doxorubicin—testicular cancer	8.64e-05	0.000199	CcSEcCtD
Paroxetine—Paraesthesia—Epirubicin—testicular cancer	8.63e-05	0.000199	CcSEcCtD
Paroxetine—Hyperhidrosis—Doxorubicin—testicular cancer	8.6e-05	0.000198	CcSEcCtD
Paroxetine—Dyspnoea—Epirubicin—testicular cancer	8.57e-05	0.000197	CcSEcCtD
Paroxetine—Somnolence—Epirubicin—testicular cancer	8.54e-05	0.000197	CcSEcCtD
Paroxetine—Feeling abnormal—Methotrexate—testicular cancer	8.46e-05	0.000195	CcSEcCtD
Paroxetine—Dyspepsia—Epirubicin—testicular cancer	8.46e-05	0.000195	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methotrexate—testicular cancer	8.4e-05	0.000193	CcSEcCtD
Paroxetine—Decreased appetite—Epirubicin—testicular cancer	8.35e-05	0.000192	CcSEcCtD
Paroxetine—Hypotension—Doxorubicin—testicular cancer	8.31e-05	0.000191	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Epirubicin—testicular cancer	8.3e-05	0.000191	CcSEcCtD
Paroxetine—Fatigue—Epirubicin—testicular cancer	8.29e-05	0.000191	CcSEcCtD
Paroxetine—Constipation—Epirubicin—testicular cancer	8.22e-05	0.000189	CcSEcCtD
Paroxetine—Pain—Epirubicin—testicular cancer	8.22e-05	0.000189	CcSEcCtD
Paroxetine—Urticaria—Methotrexate—testicular cancer	8.16e-05	0.000188	CcSEcCtD
Paroxetine—Body temperature increased—Methotrexate—testicular cancer	8.12e-05	0.000187	CcSEcCtD
Paroxetine—Abdominal pain—Methotrexate—testicular cancer	8.12e-05	0.000187	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	8.1e-05	0.000187	CcSEcCtD
Paroxetine—Insomnia—Doxorubicin—testicular cancer	8.04e-05	0.000185	CcSEcCtD
Paroxetine—Paraesthesia—Doxorubicin—testicular cancer	7.98e-05	0.000184	CcSEcCtD
Paroxetine—Dyspnoea—Doxorubicin—testicular cancer	7.93e-05	0.000183	CcSEcCtD
Paroxetine—Feeling abnormal—Epirubicin—testicular cancer	7.92e-05	0.000182	CcSEcCtD
Paroxetine—Somnolence—Doxorubicin—testicular cancer	7.9e-05	0.000182	CcSEcCtD
Paroxetine—Gastrointestinal pain—Epirubicin—testicular cancer	7.86e-05	0.000181	CcSEcCtD
Paroxetine—Dyspepsia—Doxorubicin—testicular cancer	7.83e-05	0.00018	CcSEcCtD
Paroxetine—Decreased appetite—Doxorubicin—testicular cancer	7.73e-05	0.000178	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Doxorubicin—testicular cancer	7.68e-05	0.000177	CcSEcCtD
Paroxetine—Fatigue—Doxorubicin—testicular cancer	7.67e-05	0.000177	CcSEcCtD
Paroxetine—Urticaria—Epirubicin—testicular cancer	7.63e-05	0.000176	CcSEcCtD
Paroxetine—Pain—Doxorubicin—testicular cancer	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Constipation—Doxorubicin—testicular cancer	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Body temperature increased—Epirubicin—testicular cancer	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Abdominal pain—Epirubicin—testicular cancer	7.6e-05	0.000175	CcSEcCtD
Paroxetine—Hypersensitivity—Methotrexate—testicular cancer	7.57e-05	0.000174	CcSEcCtD
Paroxetine—Asthenia—Methotrexate—testicular cancer	7.37e-05	0.00017	CcSEcCtD
Paroxetine—Feeling abnormal—Doxorubicin—testicular cancer	7.33e-05	0.000169	CcSEcCtD
Paroxetine—Gastrointestinal pain—Doxorubicin—testicular cancer	7.27e-05	0.000167	CcSEcCtD
Paroxetine—Pruritus—Methotrexate—testicular cancer	7.27e-05	0.000167	CcSEcCtD
Paroxetine—Hypersensitivity—Epirubicin—testicular cancer	7.08e-05	0.000163	CcSEcCtD
Paroxetine—Urticaria—Doxorubicin—testicular cancer	7.06e-05	0.000163	CcSEcCtD
Paroxetine—Abdominal pain—Doxorubicin—testicular cancer	7.03e-05	0.000162	CcSEcCtD
Paroxetine—Body temperature increased—Doxorubicin—testicular cancer	7.03e-05	0.000162	CcSEcCtD
Paroxetine—Diarrhoea—Methotrexate—testicular cancer	7.03e-05	0.000162	CcSEcCtD
Paroxetine—Asthenia—Epirubicin—testicular cancer	6.89e-05	0.000159	CcSEcCtD
Paroxetine—Pruritus—Epirubicin—testicular cancer	6.8e-05	0.000157	CcSEcCtD
Paroxetine—Dizziness—Methotrexate—testicular cancer	6.79e-05	0.000156	CcSEcCtD
Paroxetine—Diarrhoea—Epirubicin—testicular cancer	6.58e-05	0.000151	CcSEcCtD
Paroxetine—Hypersensitivity—Doxorubicin—testicular cancer	6.55e-05	0.000151	CcSEcCtD
Paroxetine—Vomiting—Methotrexate—testicular cancer	6.53e-05	0.00015	CcSEcCtD
Paroxetine—Rash—Methotrexate—testicular cancer	6.47e-05	0.000149	CcSEcCtD
Paroxetine—Dermatitis—Methotrexate—testicular cancer	6.47e-05	0.000149	CcSEcCtD
Paroxetine—Headache—Methotrexate—testicular cancer	6.43e-05	0.000148	CcSEcCtD
Paroxetine—Asthenia—Doxorubicin—testicular cancer	6.38e-05	0.000147	CcSEcCtD
Paroxetine—Dizziness—Epirubicin—testicular cancer	6.35e-05	0.000146	CcSEcCtD
Paroxetine—Pruritus—Doxorubicin—testicular cancer	6.29e-05	0.000145	CcSEcCtD
Paroxetine—Vomiting—Epirubicin—testicular cancer	6.11e-05	0.000141	CcSEcCtD
Paroxetine—Nausea—Methotrexate—testicular cancer	6.1e-05	0.00014	CcSEcCtD
Paroxetine—Diarrhoea—Doxorubicin—testicular cancer	6.08e-05	0.00014	CcSEcCtD
Paroxetine—Rash—Epirubicin—testicular cancer	6.06e-05	0.00014	CcSEcCtD
Paroxetine—Dermatitis—Epirubicin—testicular cancer	6.05e-05	0.000139	CcSEcCtD
Paroxetine—Headache—Epirubicin—testicular cancer	6.02e-05	0.000139	CcSEcCtD
Paroxetine—Dizziness—Doxorubicin—testicular cancer	5.88e-05	0.000135	CcSEcCtD
Paroxetine—Nausea—Epirubicin—testicular cancer	5.71e-05	0.000131	CcSEcCtD
Paroxetine—Vomiting—Doxorubicin—testicular cancer	5.65e-05	0.00013	CcSEcCtD
Paroxetine—Rash—Doxorubicin—testicular cancer	5.61e-05	0.000129	CcSEcCtD
Paroxetine—Dermatitis—Doxorubicin—testicular cancer	5.6e-05	0.000129	CcSEcCtD
Paroxetine—Headache—Doxorubicin—testicular cancer	5.57e-05	0.000128	CcSEcCtD
Paroxetine—Nausea—Doxorubicin—testicular cancer	5.28e-05	0.000122	CcSEcCtD
